Matteo and Laurent appeared respectively in two radio show broadcasted on the Swiss Radio RTS. They discuss the today’s problematic of animal testing and how the technology developed by Nagi Bioscience can…
Our CSO Laurent Mouchiroud received the prestigious PERL (Prix Entreprendre Région Lausanne) Biotech Award 2018 during a ceremony held at the Theatre de Beaulieu in Lausanne. Each year, the PERL jury, made up of…
An interview with Matteo Cornaglia, our CEO, was published on te front page of the EPFL website, providing some insight about the how and why of the technology developed by Nagi Bioscience….
Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team. The members of this team, the venture leaders, win a week entrepreneurial and business…
Great news: Nagi Bioscience passed stage 1 of Venture Kick! On the way for stage 2 now! Venture Kick was launched in 2007 with the vision to double the number of spin-offs at Swiss universities, to…
We are glad and very proud to be among the TOP50 start-up in which to invest in 2018 selected by the prestigious swiss economic newspaper Bilan. Every year, the magazine Bilan selects 50 of…
Nagi Bioscience is featured today in the Swiss newspaper Le Temps. This article (in French) discusses the current problematic of animal testing in the scientific research and highlight the solution developed by Nagi…
From tomorrow morning till Friday evening, Nagi Bioscience will attend the Hello Tomorrow Summit in Paris as one of the World’s TOP500 Deep-Tech Startups. We are glad to be one of the startups selected…
We are delighted to announce that our team will pitch the technology developed by Nagi Bioscience during the ILMAC Lausanne exhibition on Thursday, the 5th of October. The first-ever edition of ILMAC LAUSANNE is taking…
From September 10th to 13th, Nagi Bioscience attended the 53rd Congress of the European Societies of Toxicology (EuroTox) in Bratislava. Our team presented for the first time a poster with the latest results obtained in…